Review article: The role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 387, Issue 7, 2014, Pages 605-620

  Piechota Polanczyk, Aleksandra ^a   Fichna, Jakub ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Anti TNF antibodies; Antioxidants; Corticosteroids; Crohn's disease; Free radicals; Ulcerative colitis

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; ANTIOXIDANT; CORTICOSTEROID; CURCUMIN; CYCLOSPORIN A; CYTOKINE; FREE RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; MESALAZINE; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SALAZOSULFAPYRIDINE; THIOCTIC ACID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; ANTIINFLAMMATORY AGENT;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; COLITIS ASSOCIATED COLORECTAL CANCER; COLORECTAL CANCER; CROHN DISEASE; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; HUMAN; INFLAMMATORY BOWEL DISEASE; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; RELAPSE; REVIEW; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS; ANIMAL; GASTROINTESTINAL TRACT; INFLAMMATORY BOWEL DISEASES; METABOLISM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATORY BOWEL DISEASES; LIPID PEROXIDATION; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 84904035090     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-014-0985-1     Document Type: Review

References (144)

1. Abdel-Aziz H, Wadie W, Abdallah DM, Lentzen G, Khayyal MT (2013) Novel effects of ectoine, a bacteria-derived natural tetrahydropyrimidine, in experimental colitis. Phytomedicine : international journal of phytotherapy and phytopharmacology
2. Agnholt J, Kaltoft K (2001) Infliximab downregulates interferon-gamma production in activated gut T-lymphocytes from patients with Crohn's disease. Cytokine 15:212-222 (Pubitemid 34587646)
3. Ancha HR, Kurella RR, McKimmey CC, Lightfoot S, Harty RF (2009) Effects of N-acetylcysteine plus mesalamine on prostaglandin synthesis and nitric oxide generation in TNBS-induced colitis in rats. Dig Dis Sci 54:758-766
4. Ardite E, Panes J, Miranda M, Salas A, Elizalde JI, Sans M, Arce Y, Bordas JM, Fernandez-Checa JC, Pique JM (1998) Effects of steroid treatment on activation of nuclear factor kappaB in patients with inflammatory bowel disease. Br J Pharmacol 124:431-433 (Pubitemid 28254496)
5. Arijs I, De Hertogh G, Machiels K, Van Steen K, Lemaire K, Schraenen A, Van Lommel L, Quintens R, Van Assche G, Vermeire S, Schuit F, Rutgeerts P (2011) Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatment. Am J Gastroenterol 106:748-761
6. Aw TY (2005) Intestinal glutathione: determinant of mucosal peroxide transport, metabolism, and oxidative susceptibility. Toxicol Appl Pharmacol 204:320-328
7. Bachhawat AK, Thakur A, Kaur J, Zulkifli M (2013) Glutathione transporters. Biochim Biophys Acta 1830:3154-3164
8. Baert FJ, D'Haens GR, Peeters M, Hiele MI, Schaible TF, Shealy D, Geboes K, Rutgeerts PJ (1999) Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. Gastroenterology 116:22-28 (Pubitemid 29013489)
9. Baliga MS, Joseph N, Venkataranganna MV, Saxena A, Ponemone V, Fayad R (2012) Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: preclinical and clinical observations. Food funct 3:1109-1117
10. Bantel H, Schmitz ML, Raible A, Gregor M, Schulze-Osthoff K (2002) Critical role of NF-kappaB and stress-activated protein kinases in steroid unresponsiveness. FASEB J official Publ Fed Am Soc Exp Biol 16:1832-1834
11. Bao Y, Jemth P, Mannervik B, Williamson G (1997) Reduction of thymine hydroperoxide by phospholipid hydroperoxide glutathione peroxidase and glutathione transferases. FEBS Lett 410:210-212 (Pubitemid 27304066)
12. Bao S, Carr ED, Xu YH, Hunt NH (2011) Gp91 (phox) contributes to the development of experimental inflammatory bowel disease. Immunol Cell Biol 89:853-860
13. Beltran B, Nos P, Dasi F, Iborra M, Bastida G, Martinez M, O'Connor JE, Saez G, Moret I, Ponce J (2010) Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naive and treated Crohn's disease. Inflamm Bowel Dis 16:76-86
14. Biagioni C, Favilli F, Catarzi S, Marcucci T, Fazi M, Tonelli F, Vincenzini MT, Iantomasi T (2006) Redox state and O2*- production in neutrophils of Crohn's disease patients. Exp Biol Med 231:186-195 (Pubitemid 43213456)
15. Binion DG, Rafiee P, Ramanujam KS, Fu S, Fisher PJ, Rivera MT, Johnson CP, Otterson MF, Telford GL, Wilson KT (2000) Deficient iNOS in inflammatory bowel disease intestinal microvascular endothelial cells results in increased leukocyte adhesion. Free Radic Biol Med 29:881-888
16. Bjorndal B, Grimstad T, Cacabelos D, Nylund K, Aasprong OG, Omdal R, Portero-Otin M, Pamplona R, Lied GA, Hausken T, Berge RK (2013) Tetradecylthioacetic acid attenuates inflammation and has antioxidative potential during experimental colitis in rats. Dig Dis Sci 58:97-106
17. Boehm D, Krzystek-Korpacka M, Neubauer K, Matusiewicz M, Paradowski L, Gamian A (2012) Lipid peroxidation markers in Crohn's disease: the associations and diagnostic value. Clin Chem Lab Med CCLM/FESCC 50:1359-1366
18. Boschetti G, Nancey S, Sardi F, Roblin X, Flourie B, Kaiserlian D (2011) Therapy with anti-TNFalpha antibody enhances number and function of Foxp3 (+) regulatory Tcells in inflammatory bowel diseases. Inflamm Bowel Dis 17:160-170
19. Brennan FM, Maini RN, Feldmann M (1995) Cytokine expression in chronic inflammatory disease. Br Med Bull 51:368-384
20. Brindley DN, Abousalham A, Kikuchi Y, Wang CN, Waggoner DW (1996) "Cross talk" between the bioactive glycerolipids and sphingolipids in signal transduction. biochemistry and cell biology. Biochim Biol Cell 74:469-476 (Pubitemid 126734109)
21. Campregher C, Luciani MG, Biesenbach P, Evstatiev R, Lyakhovich A, Gasche C (2010) The position of the amino group on the benzene ring is critical for mesalamine's improvement of replication fidelity. Inflamm Bowel Dis 16:576-582
22. Catala A (2009) Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem Phys Lipids 157:1-11
23. Cetinkaya A, Bulbuloglu E, Kurutas EB, Ciralik H, Kantarceken B, Buyukbese MA (2005) Beneficial effects of N-acetylcysteine on acetic acid-induced colitis in rats. Tohoku J Exp Med 206:131-139 (Pubitemid 40895042)
24. Chang LC, Fan CW, Tseng WK, Chen JR, Chein HP, Hwang CC, Hua CC (2013) Immunohistochemical study of the Nrf2 pathway in colorectal cancer: Nrf2 expression is closely correlated to Keap1 in the tumor and Bach1 in the normal tissue. Applied immunohistochemistry & molecular morphology : AIMM/official publication of the Society for Applied Immunohistochemistry
25. Chawla N, Butler EN, Lund J, Warren JL, Harlan LC, Yabroff KR (2013) Patterns of colorectal cancer care in Europe, Australia, and New Zealand. J Natl Cancer Inst Monogr 2013:36-61
26. Chen QK, Yuan SZ, Wen ZF, Zhong YQ, Li CJ, Wu HS, Mai CR, Xie PY, Lu YM, Yu ZL (2005) Characteristics and therapeutic efficacy of sulfasalazine in patients with mildly and moderately active ulcerative colitis. World J Gastroenterol:WJG 11:2462-2466
27. Chen X, Zhai X, Shi J, Liu WW, Tao H, Sun X, Kang Z (2013) Lactulose mediates suppression of dextran sodium sulfate-induced colon inflammation by increasing hydrogen production. Digestive diseases and sciences
28. Cuffari C, Seidman EG, Latour S, Theoret Y (1996) Quantitation of 6-thioguanine in peripheral blood leukocyte DNA in Crohn's disease patients on maintenance 6-mercaptopurine therapy. Can J Physiol Pharmacol 74:580-585 (Pubitemid 26341481)
29. Curran FT, Allan RN, Keighley MR (1991) Superoxide production by Crohn's disease neutrophils. Gut 32:399-402
30. Daehn I, Karran P (2009) Immune effector cells produce lethal DNA damage in cells treated with a thiopurine. Cancer Res 69:2393-2399
31. Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103:239-252
32. de Mochel NS, Seronello S, Wang SH, Ito C, Zheng JX, Liang TJ, Lambeth JD, Choi J (2010) Hepatocyte NAD (P) H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection. Hepatology 52:47-59
33. D'Haens G, Geboes K, Rutgeerts P (1999) Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine. Gastrointest Endosc 50:667-671 (Pubitemid 29518050)
34. Dijkstra G, Moshage H, van Dullemen HM, de Jager-Krikken A, Tiebosch AT, Kleibeuker JH, Jansen PL, van Goor H (1998) Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J Pathol 186:416-421 (Pubitemid 29005462)
35. Dutta S, Rittinger K (2010) Regulation of NOXO1 activity through reversible interactions with p22 and NOXA1. PLoS One 5:e10478
36. Ebert EC, Mehta V, Das KM (2005) Activation antigens on colonic T cells in inflammatory bowel disease: effects of IL-10. Clin Exp Immunol 140:157-165 (Pubitemid 40461085)
37. Egan LJ, Sandborn WJ, Tremaine WJ (1998) Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine. Am J Gastroenterol 93:442-448 (Pubitemid 29068353)
38. Esworthy RS, Swiderek KM, Ho YS, Chu FF (1998) Selenium-dependent glutathione peroxidase-GI is a major glutathione peroxidase activity in the mucosal epithelium of rodent intestine. Biochim Biophys Acta 1381:213-226 (Pubitemid 28345103)
39. Florian S, Krehl S, Loewinger M, Kipp A, Banning A, Esworthy S, Chu FF, Brigelius-Flohe R (2010) Loss of GPx2 increases apoptosis, mitosis, and GPx1 expression in the intestine of mice. Free Radic Biol Med 49:1694-1702
40. Fransen M, Nordgren M, Wang B, Apanasets O (2012) Role of peroxisomes in ROS/RNS-metabolism: implications for human disease. Biochim Biophys Acta 1822:1363-1373
41. Fratila OC, Craciun C (2010) Ultrastructural evidence ofmucosal healing after infliximab in patients with ulcerative colitis. J Gastrointest Liver Dis:JGLD 19:147-153
42. 2-.), superoxide dismutases, and related matters. J Biol Chem 272:18515-18517
43. Gan HT, Chen YQ, Ouyang Q (2005) Sulfasalazine inhibits activation of nuclear factor-kappaB in patients with ulcerative colitis. J Gastroenterol Hepatol 20:1016-1024
44. Geiszt M, Lekstrom K, Brenner S, Hewitt SM, Dana R, Malech HL, Leto TL (2003) NAD (P) H oxidase 1, a product of differentiated colon epithelial cells, can partially replace glycoprotein 91phox in the regulated production of superoxide by phagocytes. J Immunol 171:299-306 (Pubitemid 36745301)
45. Ghafourifar P, Cadenas E (2005) Mitochondrial nitric oxide synthase. Trends Pharmacol Sci 26:190-195 (Pubitemid 40432654)
46. Graham PM, Li JZ, Dou X, Zhu H, Misra HP, Jia Z, Li Y (2013) Protection against peroxynitrite-induced DNA damage by mesalamine: implications for anti-inflammation and anti-cancer activity. Mol Cell Biochem 378:291-298
47. Guijarro LG, Mate J, Gisbert JP, Perez-Calle JL, Marin-Jimenez I, Arriaza E, Olleros T, Delgado M, Castillejo MS, Prieto-Merino D, Gonzalez Lara V, Pena AS (2008) N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: randomized, placebo-controlled pilot study. World J Gastroenterol:WJG 14:2851-2857
48. Guo W, Zhao Y, Zhang Z, Tan N, Zhao F, Ge C, Liang L, Jia D, Chen T, Yao M, Li J, He X (2011) Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma. Cancer Lett 312:55-61
49. Halliwell B (1999) Oxygen and nitrogen are pro-carcinogens. Damage to DNA by reactive oxygen, chlorine and nitrogen species: measurement, mechanism and the effects of nutrition. Mutat Res 443:37-52
50. Hart AL, Ng SC (2010) Review article: the optimal medical management of acute severe ulcerative colitis. Aliment Pharmacol Ther 32:615-627
51. Hsu WH, Hsieh YS, Kuo HC, Teng CY, Huang HI, Wang CJ, Yang SF, Liou YS, Kuo WH (2007) Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL. Arch Toxicol 81:719-728
52. Ina K, Kusugami K, Shimada M, Tsuzuki T, Nishio Y, Binion DG, Imada A, Ando T (2002) Suppressive effects of cyclosporine A on neutrophils and T cells may be related to therapeutic benefits in patients with steroid-resistant ulcerative colitis. Inflamm Bowel Dis 8:1-9
53. Ischiropoulos H, Al-Mehdi AB (1995) Peroxynitrite-mediated oxidative protein modifications. FEBS Lett 364:279-282
54. Iwata S, Hori T, Sato N, Hirota K, Sasada T, Mitsui A, Hirakawa T, Yodoi J (1997) Adult T cell leukemia (ATL)-derived factor/human thioredoxin prevents apoptosis of lymphoid cells induced by L-cystine and glutathione depletion: possible involvement of thiol-mediated redox regulation in apoptosis caused by pro-oxidant state. J Immunol 158:3108-3117 (Pubitemid 127484023)
55. Khodayari S, Salehi Z, Fakhrieh Asl S, Aminian K, Mirzaei Gisomi N, Torabi Dalivandan S (2013) Catalase gene C-262T polymorphism: importance in ulcerative colitis. Journal of gastroenterology and hepatology
56. Kim H, Kim KH (1998) Effect of nitric oxide on hydrogen peroxide-induced damage in isolated rabbit gastric glands. Pharmacology 57:323-330 (Pubitemid 28510969)
57. Kim M, Lee S, Yang SK, Song K, Lee I (2006) Differential expression in histologically normal crypts of ulcerative colitis suggests primary crypt disorder. Oncol Rep 16:663-670
58. Kim JY, Cho HJ, Sir JJ, Kim BK, Hur J, Youn SW, Yang HM, Jun SI, Park KW, Hwang SJ, Kwon YW, Lee HY, Kang HJ, Oh BH, Park YB, Kim HS (2009) Sulfasalazine induces haem oxygenase-1 via ROS-dependent Nrf2 signalling, leading to control of neointimal hyperplasia. Cardiovasc Res 82:550-560
59. Kimura I, Kawasaki M, Matsuda A, Kataoka M, Kokurba Y (1998) Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine. Arzneimittelforschung 48:1163-1167 (Pubitemid 29006237)
60. Kimura H, Sato Y, Tajima Y, Suzuki H, Yukitake H, Imaeda T, Kajino M, Oki H, Takizawa M, Tanida S (2010) BTZO-1, a cardioprotective agent, reveals that macrophage migration inhibitory factor regulates ARE-mediated gene expression. Chem Biol 17:1282-1294
61. King N, Lin H, Suleiman MS (2011) Oxidative stress increases SNAT1 expression and stimulates cysteine uptake in freshly isolated rat cardiomyocytes. Amino Acids 40:517-526
62. Kolgazi M, Jahovic N, Yuksel M, Ercan F, Alican I (2007) Alpha-lipoic acid modulates gut inflammation induced by trinitrobenzene sulfonic acid in rats. J Gastroenterol Hepatol 22:1859-1865 (Pubitemid 47525046)
63. Kountouras J, Zavos C, Chatzopoulos D (2004) Immunomodulatory benefits of cyclosporine a in inflammatory bowel disease. J Cell Mol Med 8:317-328 (Pubitemid 44145495)
64. Krieglstein CF, Cerwinka WH, Laroux FS, Salter JW, Russell JM, Schuermann G, Grisham MB, Ross CR, Granger DN (2001) Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide. J Exp Med 194:1207-1218 (Pubitemid 33055040)
65. Kruidenier L, Verspaget HW (2002) Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease - radicals or ridiculous? Aliment Pharmacol Ther 16:1997-2015 (Pubitemid 36009163)
66. Kruidenier L, Kuiper I, Lamers CB, Verspaget HW (2003) Intestinal oxidative damage in inflammatory bowel disease: semiquantification, localization, and association with mucosal antioxidants. J Pathol 201:28-36 (Pubitemid 37121200)
67. Kuhn H, Borchert A (2002) Regulation of enzymatic lipid peroxidation: the interplay of peroxidizing and peroxide reducing enzymes. Free Radic Biol Med 33:154-172 (Pubitemid 34775188)
68. Leonard N, Bishop AE, Polak JM, Talbot IC (1998) Expression of nitric oxide synthase in inflammatory bowel disease is not affected by corticosteroid treatment. J Clin Pathol 51:750-753 (Pubitemid 28480331)
69. Leonel AJ, Teixeira LG, Oliveira RP, Santiago AF, Batista NV, Ferreira TR, Santos RC, Cardoso VN, Cara DC, Faria AM, Alvarez-Leite J (2012) Antioxidative and immunomodulatory effects of tributyrin supplementation on experimental colitis. Br J Nutr 1-12
70. Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura MP, Berger C, Chan PH, Wallace DC, Epstein CJ (1995) Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 11:376-381
71. Li Z, Arijs I, De Hertogh G, Vermeire S, Noman M, Bullens D, Coorevits L, Sagaert X, Schuit F, Rutgeerts P, Ceuppens JL, Van Assche G (2010) Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab. Inflamm Bowel Dis 16:1299-1310
72. Liptay S, Bachem M, Hacker G, Adler G, Debatin KM, Schmid RM (1999) Inhibition of nuclear factor kappa B and induction of apoptosis in T-lymphocytes by sulfasalazine. Br J Pharmacol 128:1361-1369
73. Liu X, Wang JM (2011) Iridoid glycosides fraction of Folium syringae leaves modulates NF-kappaB signal pathway and intestinal epithelial cells apoptosis in experimental colitis. PLoS One 6:e24740
74. Ljung T, Lundberg S, Varsanyi M, Johansson C, Schmidt PT, Herulf M, Lundberg JO, Hellstrom PM(2006) Rectal nitric oxide as biomarker in the treatment of inflammatory bowel disease: responders versus nonresponders. World J Gastroenterol:WJG 12:3386-3392 (Pubitemid 43933784)
75. Makitalo L, Rintamaki H, Tervahartiala T, Sorsa T, Kolho KL (2012) Serum MMPs 7-9 and their inhibitors during glucocorticoid and anti-TNF-alpha therapy in pediatric inflammatory bowel disease. Scand J Gastroenterol 47:785-794
76. Maor I, Rainis T, Lanir A, Lavy A (2008) Oxidative stress, inflammation and neutrophil superoxide release in patients with Crohn's disease: distinction between active and non-active disease. Dig Dis Sci 53:2208-2214
77. Marklund SL (1982) Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci U S A 79:7634-7638
78. Masuda H, Takahashi Y, Nishida Y, Asai S (2012) Comparison of the effect of mesalazine and sulfasalazine on laboratory parameters: a retrospective observational study. Eur J Clin Pharmacol 68:1549-1555
79. Matheson PJ, Wilson MA, Garrison RN (2000) Regulation of intestinal blood flow. J Surg Res 93:182-196
80. Miller DM, Buettner GR, Aust SD (1990) Transition metals as catalysts of "autoxidation" reactions. Free Radic Biol Med 8:95-108
81. Miralles-Barrachina O, Savoye G, Belmonte-Zalar L, Hochain P, Ducrotte P, Hecketsweiler B, Lerebours E, Dechelotte P (1999) Low levels of glutathione in endoscopic biopsies of patients with Crohn's colitis: the role of malnutrition. Clin Nutr 18:313-317 (Pubitemid 29527742)
82. Muller FL, Liu Y, Van Remmen H (2004) Complex III releases superoxide to both sides of the inner mitochondrial membrane. J Biol Chem 279:49064-49073 (Pubitemid 39625788)
83. Nielsen OH, Koppen T, Rudiger N, Horn T, Eriksen J, Kirman I (1996) Involvement of interleukin-4 and -10 in inflammatory bowel disease. Dig Dis Sci 41:1786-1793
84. Nosal'ova V, Cerna S, Bauer V (2000) Effect of N-acetylcysteine on colitis induced by acetic acid in rats. Gen Pharmacol 35:77-81 (Pubitemid 33052466)
85. Nylund CM, D'Mello S, Kim MO, Bonkowski E, Dabritz J, Foell D, Meddings J, Trapnell BC, Denson LA (2011) Granulocyte macrophage-colony-stimulating factor autoantibodies and increased intestinal permeability in Crohn disease. J Pediatr Gastroenterol Nutr 52:542-548
86. Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, Katsura K, Katayama Y, Asoh S, Ohta S (2007) Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 13:688-694 (Pubitemid 46889750)
87. Olsen T, Cui G, Goll R, Husebekk A, Florholmen J (2009) Infliximab therapy decreases the levels of TNF-alpha and IFN-gamma mRNA in colonic mucosa of ulcerative colitis. Scand J Gastroenterol 44:727-735
88. Ono K, Han J (2000) The p38 signal transduction pathway: activation and function. Cell Signal 12:1-13 (Pubitemid 30017963)
89. Park EJ, Lim JH, Nam SI, Park JW, Kwon TK (2010) Rottlerin induces heme oxygenase-1 (HO-1) up-regulation through reactive oxygen species (ROS) dependent and PKC delta-independent pathway in human colon cancer HT29 cells. Biochimie 92:110-115
90. Pearson DC, May GR, Fick GH, Sutherland LR (1995) Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med 123:132-142
91. Perner A, Andresen L, Normark M, Fischer-Hansen B, Sorensen S, Eugen-Olsen J, Rask-Madsen J (2001) Expression of nitric oxide synthases and effects of L-arginine and L-NMMA on nitric oxide production and fluid transport in collagenous colitis. Gut 49:387-394 (Pubitemid 32802574)
92. Pietarinen-Runtti P, Lakari E, Raivio KO, Kinnula VL (2000) Expression of antioxidant enzymes in human inflammatory cells. Am J Physiol Cell Physiol 278:C118-C125 (Pubitemid 30101902)
93. Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347: 417-429
94. Poli G, Schaur RJ, Siems WG, Leonarduzzi G (2008) 4-Hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Med Res Rev 28:569-631 (Pubitemid 351842143)
95. Poulsen NA, Andersen V, Moller JC, Moller HS, Jessen F, Purup S, Larsen LB (2012) Comparative analysis of inflamed and non-inflamed colon biopsies reveals strong proteomic inflammation profile in patients with ulcerative colitis. BMC Gastroenterol 12:76
96. Pruzanski W, Stefanski E, Vadas P, Ramamurthy NS (1997) Inhibition of extracellular release of proinflammatory secretory phospholipase A2 (sPLA2) by sulfasalazine: a novel mechanism of antiinflammatory activity. Biochem Pharmacol 53:1901-1907 (Pubitemid 27356063)
97. Rachmilewitz D, Stamler JS, Bachwich D, Karmeli F, Ackerman Z, Podolsky DK (1995) Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 36:718-723
98. Raddatz D, Bockemuhl M, Ramadori G (2005) Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome. Eur J Gastroenterol Hepatol 17:547-557 (Pubitemid 40592713)
99. Rafa H, Saoula H, Belkhelfa M, Medjeber O, Soufli I, Toumi R, de Launoit Y, Morales O, Nakmouche M, Delhem N, Touil-Boukoffa C (2013) IL-23/IL-17A axis correlates with the nitric oxide pathway in inflammatory bowel disease: immunomodulatory effect of retinoic acid. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
100. Rahman I, Smith CA, Antonicelli F, MacNee W (1998) Characterisation of gamma-glutamylcysteine synthetase-heavy subunit promoter: a critical role for AP-1. FEBS Lett 427:129-133 (Pubitemid 28210110)
101. Reddy NM, Kleeberger SR, Bream JH, Fallon PG, Kensler TW, Yamamoto M, Reddy SP (2008) Genetic disruption of the Nrf2 compromises cell-cycle progression by impairing GSH-induced redox signaling. Oncogene 27:5821-5832
102. Ridnour LA, Isenberg JS, Espey MG, Thomas DD, Roberts DD, Wink DA (2005) Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1. Proc Natl Acad Sci U S A 102: 13147-13152 (Pubitemid 41324993)
103. Rijk MC, van Schaik A, van Tongeren JH (1988) Disposition of 5- aminosalicylic acid by 5-aminosalicylic acid-delivering compounds. Scand J Gastroenterol Suppl 148:54-59 (Pubitemid 19003582)
104. Rismo R, Olsen T, Ciu G, Paulssen EJ, Christiansen I, Florholmen J, Goll R (2012) The effect of adalimumab for induction of endoscopic healing and normalization of mucosal cytokine gene expression in Crohn's disease. Scand J Gastroenterol 47:1200-1210
105. Romagnoli C, Marcucci T, Picariello L, Tonelli F, Vincenzini MT, Iantomasi T (2012) Role of N-acetylcysteine and GSH redox system on total and active MMP-2 in intestinal myofibroblasts of Crohn's disease patients. International journal of colorectal disease
106. Rosillo MA, Sanchez-Hidalgo M, Cardeno A, de la Lastra CA (2011) Protective effect of ellagic acid, a natural polyphenolic compound, in a murine model of Crohn's disease. Biochem Pharmacol 82:737-745
107. Russo I, Luciani A, De Cicco P, Troncone E, Ciacci C (2012) Butyrate attenuates lipopolysaccharide-induced inflammation in intestinal cells and Crohn'smucosa throughmodulation of antioxidant defense machinery. PLoS One 7:e32841
108. Sanders LM, Henderson CE, Hong MY, Barhoumi R, Burghardt RC, Carroll RJ, Turner ND, Chapkin RS, Lupton JR (2004) Pro-oxidant environment of the colon compared to the small intestine may contribute to greater cancer susceptibility. Cancer Lett 208:155-161
109. Scharlau D, Borowicki A, Habermann N, Hofmann T, Klenow S, Miene C, Munjal U, Stein K, Glei M (2009) Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre. Mutat Res 682:39-53
110. Scherer DC, Brockman JA, Chen Z, Maniatis T, Ballard DW (1995) Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. Proc Natl Acad Sci U S A 92:11259-11263 (Pubitemid 3015352)
111. Schreiber S, Nikolaus S, Hampe J (1998) Activation of nuclear factor kappa B inflammatory bowel disease. Gut 42:477-484 (Pubitemid 28186562)
112. Schuhmacher S, Oelze M, Bollmann F, Kleinert H, Otto C, Heeren T, Steven S, Hausding M, Knorr M, Pautz A, Reifenberg K, Schulz E, Gori T, Wenzel P, Munzel T, Daiber A (2011) Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapy. Diabetes 60:2608-2616
113. Seiler A, Schneider M, Forster H, Roth S, Wirth EK, Culmsee C, Plesnila N, Kremmer E, Radmark O, Wurst W, Bornkamm GW, Schweizer U, Conrad M (2008) Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF mediated cell death. Cell Metab 8:237-248
114. Seril DN, Liao J, Ho KL, Yang CS, Yang GY (2002) Inhibition of chronic ulcerative colitis-associated colorectal adenocarcinoma development in a murine model by N-acetylcysteine. Carcinogenesis 23:993-1001 (Pubitemid 34752955)
115. Seril DN, Liao J, Yang GY, Yang CS (2003) Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 24:353-362 (Pubitemid 36432628)
116. Sies H, Sharov VS, Klotz LO, Briviba K (1997) Glutathione peroxidase protects against peroxynitrite-mediated oxidations. A new function for selenoproteins as peroxynitrite reductase. J Biol Chem 272:27812-27817 (Pubitemid 27473581)
117. Singer II, Kawka DW, Scott S, Weidner JR, Mumford RA, Riehl TE, Stenson WF (1996) Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 111:871-885 (Pubitemid 26327590)
118. Sklyarov AY, Panasyuk NB, Fomenko IS (2011) Role of nitric oxide-synthase and cyclooxygenase/lipooxygenase systems in development of experimental ulcerative colitis. Can J Physiol Pharmacol : Off J Pol Physiol Soc 62:65-73
119. Sun L, Wang X, Yao H, Li W, Son YO, Luo J, Liu J, Zhang Z (2012) Reactive oxygen species mediate Cr (VI)-induced S phase arrest through p53 in human colon cancer cells. J Environ Pathol Toxicol Oncol off organ Int Soc Environ toxic Cancer 31:95-107
120. Sydlik U, Gallitz I, Albrecht C, Abel J, Krutmann J, Unfried K (2009) The compatible solute ectoine protects against nanoparticle-induced neutrophilic lung inflammation. Am J Respir Crit Care Med 180:29-35
121. Tabatabaie T, Potts JD, Floyd RA (1996) Reactive oxygen species-mediated inactivation of pyruvate dehydrogenase. Arch Biochem Biophys 336:290-296 (Pubitemid 26428244)
122. Takeuchi T, Nakajima M, Morimoto K (1996) Relationship between the intracellular reactive oxygen species and the induction of oxidative DNA damage in human neutrophil-like cells. Carcinogenesis 17: 1543-1548 (Pubitemid 26280373)
123. Tan S, Yokoyama Y, Dickens E, Cash TG, Freeman BA, Parks DA (1993) Xanthine oxidase activity in the circulation of rats following hemorrhagic shock. Free Radic Biol Med 15:407-414 (Pubitemid 23283557)
124. Te Velde AA, Pronk I, de Kort F, Stokkers PC (2008) Glutathione peroxidase 2 and aquaporin 8 as new markers for colonic inflammation in experimental colitis and inflammatory bowel diseases: an important role for H2O2? Eur J Gastroenterol Hepatol 20:555-560 (Pubitemid 351667896)
125. Tham DM, Whitin JC, Kim KK, Zhu SX, Cohen HJ (1998) Expression of extracellular glutathione peroxidase in human and mouse gastrointestinal tract. Am J Physiol 275:G1463-G1471
126. Tsunada S, Iwakiri R, Ootani H, Aw TY, Fujimoto K (2003) Redox imbalance in the colonic mucosa of ulcerative colitis. Scand J Gastroenterol 38:1002-1003 (Pubitemid 37153632)
127. Tuzun A, Erdil A, Inal V, Aydin A, Bagci S, Yesilova Z, Sayal A, Karaeren N, Dagalp K (2002) Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease. Clin Biochem 35:569-572 (Pubitemid 35462134)
128. Uchiyama K, Naito Y, Takagi T, Mizushima K, Hirai Y, Hayashi N, Harusato A, Inoue K, Fukumoto K, Yamada S, Handa O, Ishikawa T, Yagi N, Kokura S, Yoshikawa T (2012) Serpin B1 protects colonic epithelial cell via blockage of neutrophil elastase activity and its expression is enhanced in patients with ulcerative colitis. Am J Physiol Gastrointest Liver Physiol 302:G1163-G1170
129. Uraz S, Tahan G, Aytekin H, Tahan V (2013) N-acetylcysteine expresses powerful anti-inflammatory and antioxidant activities resulting in complete improvement of acetic acid-induced colitis in rats. Scand J Clin Lab Invest 73:61-66
130. Valko M, Morris H, Mazur M, Rapta P, Bilton RF (2001) Oxygen free radical generating mechanisms in the colon: do the semiquinones of vitamin K play a role in the aetiology of colon cancer? Biochim Biophys Acta 1527:161-166 (Pubitemid 32710142)
131. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44-84 (Pubitemid 44566469)
132. Verspaget HW, Mieremet-Ooms MA, Weterman IT, Pena AS (1984) Partial defect of neutrophil oxidative metabolism in Crohn's disease. Gut 25:849-853 (Pubitemid 14053533)
133. Verspaget HW, Pena AS, Weterman IT, Lamers CB (1988) Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content. Gut 29:223-228 (Pubitemid 18078892)
134. Waetzig GH, Seegert D, Rosenstiel P, Nikolaus S, Schreiber S (2002) p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease. J Immunol 168:5342-5351 (Pubitemid 34496003)
135. Wakeman D, Guo J, Santos JA, Wandu WS, Schneider JE, McMellen ME, Leinicke JA, Erwin CR, Warner BW (2012) p38 MAPK regulates Bax activity and apoptosis in enterocytes at baseline and after intestinal resection. Am J Physiol Gastrointest Liver Physiol 302:G997-G1005
136. Wendland BE, Aghdassi E, Tam C, Carrrier J, Steinhart AH, Wolman SL, Baron D, Allard JP (2001) Lipid peroxidation and plasma antioxidant micronutrients in Crohn disease. Am J Clin Nutr 74:259-264 (Pubitemid 32702495)
137. Winczura A, Zdzalik D, Tudek B (2012) Damage of DNA and proteins by major lipid peroxidation products in genome stability. Free Radic Res 46:442-459
138. Wu G, Knabe DA, Yan W, Flynn NE (1995) Glutamine and glucose metabolism in enterocytes of the neonatal pig. Am J Physiol 268:R334-R342
139. Yamamoto T, Umegae S, Matsumoto K (2009) Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study. Inflamm Bowel Dis 15:1460-1466
140. Yasukawa K, Tokuda H, Tun X, Utsumi H, Yamada K (2012) The detrimental effect of nitric oxide on tissue is associated with inflammatory events in the vascular endothelium and neutrophils in mice with dextran sodium sulfate-induced colitis. Free Radic Res 46:1427-1436
141. Yuan W, Ge H, He B (2010) Pro-inflammatory activities induced by CyPA-EMMPRIN interaction in monocytes. Atherosclerosis 213:415-421
142. Yukitake H, Kimura H, Suzuki H, Tajima Y, Sato Y, Imaeda T, Kajino M, Takizawa M (2011) BTZO-15, an ARE-activator, ameliorates DSS- and TNBS-induced colitis in rats. PLoS One 6:e23256
143. Zhao ZJ, Xiang JY, Liu L, Huang XL, Gan HT (2012) Parthenolide, an inhibitor of the nuclear factor-kappaB pathway, ameliorates dextran sulfate sodium-induced colitis in mice. Int Immunopharmacol 12:169-174
144. Zwolinska-Wcislo M, Brzozowski T, Ptak-Belowska A, Targosz A, Urbanczyk K, Kwiecien S, Sliwowski Z (2011) Nitric oxide-releasing aspirin but not conventional aspirin improves healing of experimental colitis. World J Gastroenterol:WJG 17:4076-4089